Progesterone [EPC]

Progesterone [EPC] was reported 23765 times

These side effects are most commonly reported by patients taking drugs of the Progesterone [EPC] class:

# Drug class Count
0 HEADACHE 2188
1 OFF LABEL USE 1901
2 FATIGUE 1872
3 DRUG INEFFECTIVE 1864
4 NAUSEA 1550
5 PAIN 1527
6 RASH 1025
7 DIZZINESS 983
8 EXPOSURE DURING PREGNANCY 982
9 FOETAL EXPOSURE DURING PREGNANCY 934
10 HYPERSENSITIVITY 906
11 DIARRHOEA 871
12 HYPERHIDROSIS 867
13 MATERNAL EXPOSURE DURING PREGNANCY 836
14 BACK PAIN 813
15 INSOMNIA 813
16 PRODUCT USE ISSUE 810
17 ARTHRALGIA 806
18 CONSTIPATION 777
19 ANXIETY 770
20 PYREXIA 747
21 ASTHMA 741
22 HYPERTENSION 725
23 RHEUMATOID ARTHRITIS 721
24 DRUG HYPERSENSITIVITY 718
25 DYSPNOEA 708
26 HEPATIC ENZYME INCREASED 696
27 PRURITUS 689
28 ERYTHEMA 664
29 UPPER RESPIRATORY TRACT INFECTION 643
30 MALAISE 631
31 FOOD ALLERGY 628
32 JOINT SWELLING 625
33 IMMUNODEFICIENCY 615
34 RASH ERYTHEMATOUS 610
35 VOMITING 601
36 FEELING ABNORMAL 594
37 FLUID RETENTION 571
38 DEPRESSION 560
39 WEIGHT INCREASED 556
40 PRODUCT USE IN UNAPPROVED INDICATION 551
41 OVERDOSE 543
42 HOT FLUSH 508
43 INFUSION RELATED REACTION 502
44 TEMPERATURE REGULATION DISORDER 494
45 INTENTIONAL PRODUCT MISUSE 492
46 PAIN IN EXTREMITY 477
47 PRODUCT ADHESION ISSUE 477
48 ASTHENIA 470
49 BREAST CANCER 467
50 PRESCRIBED OVERDOSE 464
51 BURSITIS 454
52 PSORIASIS 453
53 ABDOMINAL PAIN 449
54 COELIAC DISEASE 447
55 ABORTION SPONTANEOUS 445
56 COVID-19 438
57 MUSCLE SPASMS 436
58 PRODUCT DOSE OMISSION ISSUE 436
59 VAGINAL HAEMORRHAGE 430
60 CONDITION AGGRAVATED 429
61 DRUG INTOLERANCE 429
62 THROMBOCYTOPENIA 425
63 INJECTION SITE PAIN 423
64 WEIGHT DECREASED 422
65 ALOPECIA 420
66 CONTRAINDICATED PRODUCT ADMINISTERED 419
67 COUGH 414
68 SOMNOLENCE 399
69 ABDOMINAL PAIN UPPER 396
70 INFECTION 391
71 MIGRAINE 391
72 FALL 381
73 NASOPHARYNGITIS 367
74 PREMATURE BABY 365
75 OVARIAN HYPERSTIMULATION SYNDROME 361
76 SINUSITIS 347
77 ABDOMINAL DISTENSION 342
78 URTICARIA 338
79 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 332
80 FOETAL DEATH 331
81 PRODUCT QUALITY ISSUE 330
82 PARAESTHESIA 325
83 TREATMENT FAILURE 324
84 PALPITATIONS 320
85 PRODUCT SUBSTITUTION ISSUE 306
86 ABDOMINAL DISCOMFORT 297
87 VISION BLURRED 297
88 URINARY TRACT INFECTION 294
89 BLOOD PRESSURE INCREASED 291
90 GAIT DISTURBANCE 286
91 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 283
92 CHEST PAIN 280
93 HEART RATE INCREASED 279
94 MYALGIA 273
95 HYPOAESTHESIA 266
96 TREMOR 264
97 INCORRECT DOSE ADMINISTERED 260
98 CHILLS 244
99 PNEUMONIA 239
100 DRUG INTERACTION 236
101 OROPHARYNGEAL PAIN 236
102 DECREASED APPETITE 232
103 BREAST CANCER FEMALE 225
104 ILLNESS 219
105 MEMORY IMPAIRMENT 219
106 INTENTIONAL PRODUCT USE ISSUE 213
107 APPLICATION SITE PRURITUS 211
108 INJECTION SITE ERYTHEMA 205
109 GASTROOESOPHAGEAL REFLUX DISEASE 203
110 PERIPHERAL SWELLING 200
111 DYSPEPSIA 197
112 MUSCULAR WEAKNESS 197
113 PREMATURE DELIVERY 196
114 STRESS 195
115 FLUSHING 192
116 APPLICATION SITE ERYTHEMA 190
117 CONTUSION 188
118 SUICIDAL IDEATION 187
119 SWELLING 186
120 EYE PAIN 182
121 INFLUENZA 181
122 BRONCHITIS 179
123 NO ADVERSE EVENT 179
124 NIGHT SWEATS 178
125 CHEST DISCOMFORT 177
126 DRY MOUTH 177
127 HYPOTENSION 177
128 CONGENITAL ANOMALY 175
129 SWELLING FACE 166
130 TINNITUS 164
131 SLEEP DISORDER 163
132 DEHYDRATION 161
133 DRY SKIN 160
134 PRODUCT ODOUR ABNORMAL 160
135 BURNING SENSATION 158
136 LOSS OF CONSCIOUSNESS 158
137 OEDEMA PERIPHERAL 157
138 INFLUENZA LIKE ILLNESS 156
139 PREMATURE LABOUR 156
140 CONFUSIONAL STATE 155
141 VISUAL IMPAIRMENT 154
142 DYSGEUSIA 153
143 FEELING HOT 152
144 ATRIAL SEPTAL DEFECT 151
145 DRUG DOSE OMISSION 151
146 DRY EYE 151
147 NECK PAIN 150
148 DISEASE RECURRENCE 149
149 VERTIGO 149
150 DEPRESSED MOOD 148
151 HAEMORRHAGE 148
152 DRUG EXPOSURE DURING PREGNANCY 145
153 DISTURBANCE IN ATTENTION 144
154 DISCOMFORT 143
155 INJECTION SITE PRURITUS 142
156 NASAL CONGESTION 142
157 ARTHRITIS 141
158 BALANCE DISORDER 139
159 DYSPHAGIA 139
160 MUSCULOSKELETAL STIFFNESS 139
161 EYE IRRITATION 138
162 GASTROINTESTINAL DISORDER 138
163 SURGERY 138
164 IRRITABILITY 137
165 ANAEMIA 135
166 PREGNANCY 135
167 THERAPEUTIC RESPONSE UNEXPECTED 134
168 PULMONARY EMBOLISM 131
169 SEIZURE 131
170 APPLICATION SITE RASH 127
171 POSTMENOPAUSAL HAEMORRHAGE 127
172 RHINORRHOEA 123
173 NEUROPATHY PERIPHERAL 122
174 UNEVALUABLE EVENT 122
175 PANIC ATTACK 121
176 INJECTION SITE REACTION 119
177 THERAPY CESSATION 119
178 BREAST TENDERNESS 117
179 CRYING 116
180 DERMATITIS ATOPIC 116
181 HYPOTHYROIDISM 116
182 NERVOUSNESS 116
183 FLATULENCE 112
184 CATARACT 111
185 INJECTION SITE SWELLING 111
186 LOW BIRTH WEIGHT BABY 111
187 METRORRHAGIA 111
188 INJECTION SITE BRUISING 110
189 TACHYCARDIA 109
190 AMNESIA 108
191 FIBROMYALGIA 107
192 SYNCOPE 107
193 RETCHING 105
194 POOR QUALITY PRODUCT ADMINISTERED 104
195 DEATH 103
196 DRUG-INDUCED LIVER INJURY 103
197 CEREBROVASCULAR ACCIDENT 102
198 EMOTIONAL DISTRESS 101
199 MOOD SWINGS 101
200 APPLICATION SITE IRRITATION 99
201 CROHN^S DISEASE 99
202 DYSPHONIA 99
203 ECZEMA 99
204 OSTEOARTHRITIS 99
205 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 99
206 VAGINAL DISCHARGE 98
207 BRAIN FOG 97
208 HYPONATRAEMIA 97
209 HERPES ZOSTER 96
210 DEEP VEIN THROMBOSIS 95
211 DEVICE ISSUE 95
212 THERAPEUTIC PRODUCT EFFECT DECREASED 95
213 LETHARGY 94
214 SKIN EXFOLIATION 94
215 THROAT IRRITATION 94
216 GESTATIONAL DIABETES 92
217 POOR QUALITY SLEEP 92
218 VENTRICULAR SEPTAL DEFECT 91
219 BLOOD CHOLESTEROL INCREASED 90
220 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90
221 FUNGAL INFECTION 89
222 NEURALGIA 89
223 BONE PAIN 88
224 LIMB DISCOMFORT 88
225 ACNE 87
226 MOBILITY DECREASED 87
227 DRUG EFFECT DECREASED 86
228 ABDOMINAL PAIN LOWER 85
229 ASCITES 85
230 HORMONE LEVEL ABNORMAL 85
231 PRODUCT STORAGE ERROR 85
232 LEUKOPENIA 84
233 RASH PRURITIC 84
234 ADVERSE DRUG REACTION 83
235 AGITATION 83
236 COGNITIVE DISORDER 83
237 DECREASED IMMUNE RESPONSIVENESS 82
238 HEAD DISCOMFORT 82
239 HYPOKALAEMIA 82
240 INFLAMMATION 82
241 SLEEP APNOEA SYNDROME 82
242 BLOOD GLUCOSE INCREASED 81
243 HEPATOTOXICITY 81
244 MATERNAL EXPOSURE BEFORE PREGNANCY 81
245 UNDERDOSE 81
246 WHITE BLOOD CELL COUNT DECREASED 81
247 CAESAREAN SECTION 80
248 INJURY 80
249 OCULAR HYPERAEMIA 80
250 THROMBOSIS 80
251 CELLULITIS 79
252 FOETAL GROWTH RESTRICTION 79
253 MIDDLE INSOMNIA 79
254 WITHDRAWAL SYNDROME 79
255 ADVERSE EVENT 78
256 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 78
257 HEART RATE DECREASED 78
258 INTERMENSTRUAL BLEEDING 78
259 OXYGEN SATURATION DECREASED 78
260 SKIN BURNING SENSATION 78
261 SPEECH DISORDER 78
262 BREAST PAIN 77
263 MULTIPLE SCLEROSIS RELAPSE 77
264 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 76
265 POLLAKIURIA 76
266 CHRONIC KIDNEY DISEASE 75
267 NEPHROLITHIASIS 75
268 DIVERTICULITIS 74
269 INJECTION SITE HAEMORRHAGE 74
270 OSTEOPOROSIS 74
271 EMOTIONAL DISORDER 73
272 MOOD ALTERED 73
273 ORAL HERPES 73
274 ATRIAL FIBRILLATION 72
275 CYSTITIS 72
276 EYE SWELLING 72
277 HOSPITALISATION 72
278 PRE-EXISTING CONDITION IMPROVED 72
279 THINKING ABNORMAL 72
280 ACCIDENTAL EXPOSURE TO PRODUCT 71
281 ANAPHYLACTIC REACTION 71
282 APPLICATION SITE PAIN 71
283 BREAST CANCER METASTATIC 71
284 MUSCULOSKELETAL PAIN 71
285 OVARIAN CYST 71
286 SMALL FOR DATES BABY 71
287 ABNORMAL DREAMS 70
288 ARTHROPATHY 70
289 CARDIAC FAILURE 70
290 PHOTOSENSITIVITY REACTION 70
291 EAR INFECTION 69
292 PSORIATIC ARTHROPATHY 69
293 INTENTIONAL DOSE OMISSION 68
294 OEDEMA 68
295 PRODUCT DOSE OMISSION 68
296 RESPIRATORY TRACT INFECTION 68
297 ACUTE KIDNEY INJURY 67
298 LIVE BIRTH 67
299 MULTIPLE SCLEROSIS 67
300 ANGER 66
301 FEELING COLD 66
302 HAEMOGLOBIN DECREASED 66
303 INTERVERTEBRAL DISC PROTRUSION 66
304 LYMPHADENOPATHY 66
305 THERAPEUTIC RESPONSE DECREASED 66
306 ECTOPIC PREGNANCY 65
307 HYPOSPADIAS 65
308 JOINT STIFFNESS 65
309 SEPSIS 65
310 SWOLLEN TONGUE 65
311 BLISTER 64
312 PLEURAL EFFUSION 64
313 PRODUCTIVE COUGH 64
314 HAEMATOCHEZIA 63
315 HALLUCINATION 63
316 HEAVY MENSTRUAL BLEEDING 63
317 INJECTION SITE URTICARIA 63
318 PRODUCT PHYSICAL ISSUE 63
319 SEASONAL ALLERGY 63
320 BLOOD PRESSURE DECREASED 62
321 CHOLELITHIASIS 62
322 HEPATIC CIRRHOSIS 62
323 MYOCARDIAL INFARCTION 62
324 PRE-ECLAMPSIA 62
325 FOOT FRACTURE 61
326 LACRIMATION INCREASED 61
327 RESTLESS LEGS SYNDROME 61
328 COLITIS ULCERATIVE 60
329 MENOPAUSAL SYMPTOMS 60
330 PELVIC PAIN 60
331 INJECTION SITE MASS 59
332 RENAL FAILURE 59
333 THERAPY INTERRUPTED 59
334 THROAT TIGHTNESS 59
335 APHASIA 58
336 BLOOD PRESSURE FLUCTUATION 58
337 DEVICE ADHESION ISSUE 58
338 DRUG WITHDRAWAL SYNDROME 58
339 DYSMENORRHOEA 58
340 MEDICATION ERROR 58
341 RESTLESSNESS 58
342 SKIN DISCOLOURATION 58
343 THERAPEUTIC RESPONSE SHORTENED 58
344 URINARY INCONTINENCE 58
345 UTERINE LEIOMYOMA 58
346 DEVICE BREAKAGE 57
347 FEELING JITTERY 57
348 GASTROENTERITIS VIRAL 57
349 HEPATIC ENCEPHALOPATHY 57
350 HEPATIC NECROSIS 57
351 HYPERSOMNIA 57
352 OLIGOHYDRAMNIOS 57
353 EPISTAXIS 56
354 EYE PRURITUS 56
355 MENINGIOMA 56
356 NIGHTMARE 56
357 PRODUCT ADMINISTRATION INTERRUPTED 56
358 FREQUENT BOWEL MOVEMENTS 55
359 GASTRITIS 55
360 ROAD TRAFFIC ACCIDENT 55
361 BLOOD OESTROGEN DECREASED 54
362 DYSURIA 54
363 ILL-DEFINED DISORDER 54
364 INSURANCE ISSUE 54
365 LIP SWELLING 54
366 DISORIENTATION 53
367 PROCEDURAL PAIN 53
368 RASH MACULAR 53
369 SINUS DISORDER 53
370 TENDONITIS 53
371 BLOOD POTASSIUM DECREASED 52
372 INJECTION SITE RASH 52
373 LOWER RESPIRATORY TRACT INFECTION 52
374 MENOPAUSE 52
375 TREATMENT NONCOMPLIANCE 52
376 UTERINE HAEMORRHAGE 52
377 VIRAL INFECTION 52
378 DIABETES MELLITUS 51
379 GENERAL PHYSICAL HEALTH DETERIORATION 51
380 IMPAIRED WORK ABILITY 51
381 MENORRHAGIA 51
382 CARDIAC DISORDER 50
383 DYSKINESIA 50
384 IRRITABLE BOWEL SYNDROME 50
385 MUSCLE TWITCHING 50
386 PATENT DUCTUS ARTERIOSUS 50
387 LIMB INJURY 49
388 PLATELET COUNT DECREASED 49
389 WHEEZING 49
390 ABNORMAL BEHAVIOUR 48
391 ANGIOEDEMA 48
392 CHROMATURIA 48
393 MATERNAL DRUGS AFFECTING FOETUS 48
394 OSTEOPENIA 48
395 PRODUCT ADMINISTRATION ERROR 48
396 SCAR 48
397 SKIN DISORDER 48
398 THERAPY NON-RESPONDER 48
399 TOXICITY TO VARIOUS AGENTS 48
400 WRONG TECHNIQUE IN DRUG USAGE PROCESS 48
401 DYSARTHRIA 47
402 FEAR 47
403 HYPERTHYROIDISM 47
404 INFUSION SITE PAIN 47
405 KIDNEY INFECTION 47
406 PREMATURE RUPTURE OF MEMBRANES 47
407 UTERINE POLYP 47
408 ALANINE AMINOTRANSFERASE INCREASED 46
409 ARRHYTHMIA 46
410 HYPOACUSIS 46
411 LUNG DISORDER 46
412 MENTAL DISORDER 46
413 NORMAL NEWBORN 46
414 PARAESTHESIA ORAL 46
415 STOMATITIS 46
416 AMENORRHOEA 45
417 DRUG EFFECT LESS THAN EXPECTED 45
418 IMPAIRED HEALING 45
419 INTESTINAL OBSTRUCTION 45
420 PHOTOPHOBIA 45
421 PRESYNCOPE 45
422 EXPIRED PRODUCT ADMINISTERED 44
423 HEPATIC STEATOSIS 44
424 HUMAN HERPESVIRUS 6 INFECTION 44
425 JOINT INJURY 44
426 SKIN IRRITATION 44
427 ASPARTATE AMINOTRANSFERASE INCREASED 43
428 CANDIDA INFECTION 43
429 DERMATITIS CONTACT 43
430 GALLBLADDER DISORDER 43
431 HYSTERECTOMY 43
432 IMPAIRED GASTRIC EMPTYING 43
433 INTERVERTEBRAL DISC DEGENERATION 43
434 MENTAL IMPAIRMENT 43
435 NEUTROPENIA 43
436 RESPIRATORY FAILURE 43
437 VULVOVAGINAL DISCOMFORT 43
438 WHITE BLOOD CELL COUNT INCREASED 43
439 EYE DISORDER 42
440 MADAROSIS 42
441 MOVEMENT DISORDER 42
442 NERVE COMPRESSION 42
443 PERIORBITAL OEDEMA 42
444 PRODUCT AVAILABILITY ISSUE 42
445 PRODUCT DOSE OMISSION IN ERROR 42
446 RESPIRATORY DISORDER NEONATAL 42
447 THYROID DISORDER 42
448 CONVULSION 41
449 CYST 41
450 DEVICE MALFUNCTION 41
451 DIPLOPIA 41
452 DISEASE PROGRESSION 41
453 HEAD INJURY 41
454 MUSCLE TIGHTNESS 41
455 NEONATAL RESPIRATORY DISTRESS SYNDROME 41
456 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 41
457 PRODUCT PRESCRIBING ERROR 41
458 RECALLED PRODUCT ADMINISTERED 41
459 SNEEZING 41
460 SUICIDE ATTEMPT 41
461 INFUSION SITE SWELLING 40
462 RENAL DISORDER 40
463 DYSSTASIA 39
464 EATING DISORDER 39
465 FEELING DRUNK 39
466 HEART RATE IRREGULAR 39
467 HEREDITARY ANGIOEDEMA 39
468 HUNGER 39
469 HYPOGLYCAEMIA 39
470 NEEDLE ISSUE 39
471 PAIN IN JAW 39
472 PAIN OF SKIN 39
473 RASH PAPULAR 39
474 STAPHYLOCOCCAL INFECTION 39
475 TOOTH INFECTION 39
476 TRANSIENT ISCHAEMIC ATTACK 39
477 BLOOD PRESSURE SYSTOLIC INCREASED 38
478 ERUCTATION 38
479 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38
480 PANCREATITIS 38
481 VITAMIN D DEFICIENCY 38
482 BLOOD CREATININE INCREASED 37
483 BUTTERFLY RASH 37
484 EAR PAIN 37
485 FOOT DEFORMITY 37
486 HAEMORRHOIDS 37
487 PRODUCT USE COMPLAINT 37
488 UPPER LIMB FRACTURE 37
489 ABORTION INDUCED 36
490 AGGRESSION 36
491 EYE INFECTION 36
492 MUSCULOSKELETAL CHEST PAIN 36
493 PROGESTERONE DECREASED 36
494 THIRST 36
495 CARPAL TUNNEL SYNDROME 35
496 DERMATITIS 35
497 FEMUR FRACTURE 35
498 INCREASED APPETITE 35
499 PERIPHERAL COLDNESS 35
500 PRODUCT PRESCRIBING ISSUE 35
501 PRODUCT TASTE ABNORMAL 35
502 PSYCHOTIC DISORDER 35
503 RECTAL HAEMORRHAGE 35
504 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35
505 BLOOD IRON DECREASED 34
506 BLOOD PRESSURE DIASTOLIC INCREASED 34
507 BREAST MASS 34
508 COLITIS 34
509 DEVICE DIFFICULT TO USE 34
510 ENDOMETRIAL THICKENING 34
511 GAIT INABILITY 34
512 HAEMANGIOMA 34
513 HYPERGLYCAEMIA 34
514 IMPAIRED QUALITY OF LIFE 34
515 JAUNDICE 34
516 NODULE 34
517 APPLICATION SITE SWELLING 33
518 BRADYCARDIA 33
519 BREAST CANCER IN SITU 33
520 C-REACTIVE PROTEIN INCREASED 33
521 ENDOMETRIOSIS 33
522 EXTRA DOSE ADMINISTERED 33
523 GASTRIC DISORDER 33
524 INFUSION SITE ERYTHEMA 33
525 MANIA 33
526 MENSTRUAL DISORDER 33
527 MICTURITION URGENCY 33
528 MITRAL VALVE INCOMPETENCE 33
529 OCULAR DISCOMFORT 33
530 PARANOIA 33
531 ROTATOR CUFF SYNDROME 33
532 SEDATION 33
533 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 33
534 BRUXISM 32
535 CARDIAC FAILURE CONGESTIVE 32
536 DYSPNOEA EXERTIONAL 32
537 EPILEPSY 32
538 HAIR GROWTH ABNORMAL 32
539 INCORRECT PRODUCT ADMINISTRATION DURATION 32
540 INTENTIONAL OVERDOSE 32
541 MATERNAL EXPOSURE TIMING UNSPECIFIED 32
542 SKIN FISSURES 32
543 SUICIDAL BEHAVIOUR 32
544 TOOTH DISORDER 32
545 VISUAL ACUITY REDUCED 32
546 WRIST FRACTURE 32
547 ANKLE FRACTURE 31
548 BLINDNESS 31
549 COMPLICATION OF DEVICE REMOVAL 31
550 DRUG ADMINISTRATION ERROR 31
551 EXPOSURE VIA SKIN CONTACT 31
552 NERVE INJURY 31
553 QUALITY OF LIFE DECREASED 31
554 RESPIRATORY DISORDER 31
555 RESPIRATORY TRACT CONGESTION 31
556 SPINAL OSTEOARTHRITIS 31
557 BACTERIAL INFECTION 30
558 DRUG PRESCRIBING ERROR 30
559 ENDOMETRIAL HYPERPLASIA 30
560 HORDEOLUM 30
561 INJECTION SITE WARMTH 30
562 KNEE ARTHROPLASTY 30
563 LIGAMENT SPRAIN 30
564 MENSTRUATION IRREGULAR 30
565 NEOPLASM PROGRESSION 30
566 TALIPES 30
567 ABASIA 29
568 AGEUSIA 29
569 BODY TEMPERATURE DECREASED 29
570 BREAST ENLARGEMENT 29
571 DRUG DOSE OMISSION BY DEVICE 29
572 EOSINOPHILIC PNEUMONIA ACUTE 29
573 GASTROENTERITIS 29
574 HAEMORRHAGE IN PREGNANCY 29
575 HYPERCHOLESTEROLAEMIA 29
576 INITIAL INSOMNIA 29
577 LABORATORY TEST ABNORMAL 29
578 LARYNGITIS 29
579 OBESITY 29
580 POOR VENOUS ACCESS 29
581 POST PROCEDURAL COMPLICATION 29
582 TOOTHACHE 29
583 TRICUSPID VALVE INCOMPETENCE 29
584 VULVOVAGINAL DRYNESS 29
585 ABORTION 28
586 CHOKING 28
587 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 28
588 DEVICE EXPULSION 28
589 DISABILITY 28
590 FEBRILE NEUTROPENIA 28
591 FEEDING DISORDER 28
592 HIATUS HERNIA 28
593 HYPOXIA 28
594 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28
595 MOUTH ULCERATION 28
596 MULTIPLE ALLERGIES 28
597 ORAL CANDIDIASIS 28
598 ORTHOSTATIC HYPOTENSION 28
599 POST-TRAUMATIC STRESS DISORDER 28
600 PRETERM PREMATURE RUPTURE OF MEMBRANES 28
601 PRODUCT PREPARATION ERROR 28
602 SINUS CONGESTION 28
603 TASTE DISORDER 28
604 TENDON PAIN 28
605 URINARY RETENTION 28
606 VITREOUS FLOATERS 28
607 ATTENTION DEFICIT HYPERACTIVITY DISORDER 27
608 BLOOD GLUCOSE DECREASED 27
609 BONE DENSITY DECREASED 27
610 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27
611 CHRONIC SINUSITIS 27
612 COLD SWEAT 27
613 DEVICE DISLOCATION 27
614 DEVICE LEAKAGE 27
615 EXOSTOSIS 27
616 HAEMATOCRIT DECREASED 27
617 HAEMATOMA 27
618 INCORRECT DRUG ADMINISTRATION DURATION 27
619 MENISCUS INJURY 27
620 NOCTURIA 27
621 ORAL DISCOMFORT 27
622 OVARIAN CANCER 27
623 PHARYNGEAL SWELLING 27
624 PSYCHIATRIC SYMPTOM 27
625 RIB FRACTURE 27
626 SYSTEMIC LUPUS ERYTHEMATOSUS 27
627 TOOTH FRACTURE 27
628 TYPE 2 DIABETES MELLITUS 27
629 APPLICATION SITE DISCOLOURATION 26
630 BODY TEMPERATURE INCREASED 26
631 CLOSTRIDIUM DIFFICILE INFECTION 26
632 GLUCOSE TOLERANCE IMPAIRED 26
633 HYPOPHAGIA 26
634 IMPAIRED DRIVING ABILITY 26
635 LIVER FUNCTION TEST INCREASED 26
636 NERVOUS SYSTEM DISORDER 26
637 PRODUCT FORMULATION ISSUE 26
638 SCIATICA 26
639 ACTIVITIES OF DAILY LIVING IMPAIRED 25
640 ANAL INCONTINENCE 25
641 ANHEDONIA 25
642 ANKYLOSING SPONDYLITIS 25
643 APPLICATION SITE BURN 25
644 BLOOD BILIRUBIN INCREASED 25
645 BLOOD TRIGLYCERIDES INCREASED 25
646 CONJUNCTIVITIS 25
647 DEATH NEONATAL 25
648 HAIR TEXTURE ABNORMAL 25
649 INJECTION SITE IRRITATION 25
650 LIBIDO DECREASED 25
651 LYMPHOCYTE COUNT DECREASED 25
652 MUSCLE STRAIN 25
653 MYASTHENIA GRAVIS 25
654 MYDRIASIS 25
655 NEONATAL ASPHYXIA 25
656 OESTROGEN RECEPTOR ASSAY POSITIVE 25
657 PRODUCT DISPENSING ERROR 25
658 PROGESTERONE RECEPTOR ASSAY POSITIVE 25
659 PULMONARY HYPERTENSION 25
660 RASH GENERALISED 25
661 RENAL PAIN 25
662 SENSORY DISTURBANCE 25
663 SKIN ULCER 25
664 TEMPERATURE INTOLERANCE 25
665 APATHY 24
666 APHONIA 24
667 AUTOIMMUNE DISORDER 24
668 COAGULOPATHY 24
669 DEAFNESS 24
670 DEPRESSED LEVEL OF CONSCIOUSNESS 24
671 DEVELOPMENTAL HIP DYSPLASIA 24
672 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 24
673 EAR DISCOMFORT 24
674 EMBEDDED DEVICE 24
675 EYE DISCHARGE 24
676 GASTROINTESTINAL PAIN 24
677 GENERALISED OEDEMA 24
678 HALLUCINATION, VISUAL 24
679 HYPERLIPIDAEMIA 24
680 MUSCULOSKELETAL DISCOMFORT 24
681 MUSCULOSKELETAL DISORDER 24
682 PHARMACEUTICAL PRODUCT COMPLAINT 24
683 SKIN LESION 24
684 SKIN REACTION 24
685 SKIN SWELLING 24
686 SPINAL OPERATION 24
687 TENDERNESS 24
688 UTERINE DISORDER 24
689 APPLICATION SITE URTICARIA 23
690 BACK DISORDER 23
691 BLADDER DISORDER 23
692 BLOOD THYROID STIMULATING HORMONE DECREASED 23
693 BREAST SWELLING 23
694 ECONOMIC PROBLEM 23
695 FACIAL PAIN 23
696 FALLOPIAN TUBE DISORDER 23
697 FOREIGN BODY IN REPRODUCTIVE TRACT 23
698 HEMIPARESIS 23
699 HYPERTENSIVE CRISIS 23
700 INJECTION SITE DISCOLOURATION 23
701 INJECTION SITE INDURATION 23
702 LIVER DISORDER 23
703 MICROCEPHALY 23
704 NEUROLOGICAL SYMPTOM 23
705 ONYCHOCLASIS 23
706 PANCREATITIS ACUTE 23
707 PARALYSIS 23
708 PHARYNGITIS 23
709 PRESCRIBED UNDERDOSE 23
710 RENAL IMPAIRMENT 23
711 RHINITIS ALLERGIC 23
712 SKIN CANCER 23
713 SKIN LACERATION 23
714 SYMPTOM RECURRENCE 23
715 TENDON RUPTURE 23
716 UPPER-AIRWAY COUGH SYNDROME 23
717 VULVOVAGINAL BURNING SENSATION 23
718 WOUND 23
719 ABNORMAL UTERINE BLEEDING 22
720 ADRENAL INSUFFICIENCY 22
721 ANOSMIA 22
722 AUTOIMMUNE THYROIDITIS 22
723 BEDRIDDEN 22
724 BLOOD URINE PRESENT 22
725 COORDINATION ABNORMAL 22
726 DEVICE USE ISSUE 22
727 DRUG TOLERANCE 22
728 EOSINOPHILIC PNEUMONIA 22
729 FOETAL DISTRESS SYNDROME 22
730 FORMICATION 22
731 GASTRIC ULCER 22
732 HYPERBILIRUBINAEMIA 22
733 HYPOTONIA NEONATAL 22
734 INCORRECT DOSE ADMINISTERED BY DEVICE 22
735 IRON DEFICIENCY ANAEMIA 22
736 JOINT RANGE OF MOTION DECREASED 22
737 PALLOR 22
738 PANCYTOPENIA 22
739 POOR FEEDING INFANT 22
740 PRURITUS GENERALISED 22
741 STREPTOCOCCAL INFECTION 22
742 UMBILICAL HERNIA 22
743 VULVOVAGINAL PRURITUS 22
744 ACUTE RESPIRATORY FAILURE 21
745 ADNEXAL TORSION 21
746 AFFECT LABILITY 21
747 APPLICATION SITE REACTION 21
748 AUTOIMMUNE DERMATITIS 21
749 BASAL CELL CARCINOMA 21
750 BONE DISORDER 21
751 CARDIAC FLUTTER 21
752 CHOLECYSTECTOMY 21
753 CYANOSIS NEONATAL 21
754 DEFORMITY 21
755 DELIRIUM 21
756 DEVICE DEFECTIVE 21
757 DRUG EFFECT INCOMPLETE 21
758 EYELID PTOSIS 21
759 FINE MOTOR SKILL DYSFUNCTION 21
760 HIP ARTHROPLASTY 21
761 INCORRECT ROUTE OF DRUG ADMINISTRATION 21
762 INTENTIONAL SELF-INJURY 21
763 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 21
764 LOWER LIMB FRACTURE 21
765 OSTEOMYELITIS 21
766 PROTEINURIA 21
767 PULMONARY MASS 21
768 SEPTIC SHOCK 21
769 SOMNAMBULISM 21
770 STRESS FRACTURE 21
771 SUSPECTED PRODUCT QUALITY ISSUE 21
772 WEIGHT FLUCTUATION 21
773 ALLERGIC REACTION TO EXCIPIENT 20
774 BACK INJURY 20
775 BLOOD PRESSURE ABNORMAL 20
776 BLOOD PRESSURE SYSTOLIC ABNORMAL 20
777 BLOOD TEST ABNORMAL 20
778 CARDIOMYOPATHY 20
779 CONCUSSION 20
780 CONGESTIVE CARDIOMYOPATHY 20
781 DECREASED ACTIVITY 20
782 ENDOMETRIAL CANCER 20
783 HAEMATURIA 20
784 HERNIA 20
785 HYPOAESTHESIA ORAL 20
786 INFUSION SITE HAEMORRHAGE 20
787 INTRA-UTERINE DEATH 20
788 IRON DEFICIENCY 20
789 LIVER FUNCTION TEST ABNORMAL 20
790 METABOLIC ACIDOSIS 20
791 MUSCLE SPASTICITY 20
792 OBSESSIVE-COMPULSIVE DISORDER 20
793 ONYCHOMYCOSIS 20
794 OVARIAN ENLARGEMENT 20
795 PANIC REACTION 20
796 PHARYNGEAL OEDEMA 20
797 PHARYNGITIS STREPTOCOCCAL 20
798 PYELONEPHRITIS 20
799 REACTION TO EXCIPIENT 20
800 SJOGREN^S SYNDROME 20
801 SKIN HAEMORRHAGE 20
802 SPEECH DISORDER DEVELOPMENTAL 20
803 TOOTH LOSS 20
804 TWIN PREGNANCY 20
805 VAGINAL INFECTION 20
806 VENTRICULAR EXTRASYSTOLES 20
807 ADVERSE REACTION 19
808 APHTHOUS ULCER 19
809 ARTHROPOD BITE 19
810 BLOOD SODIUM DECREASED 19
811 BLOOD THYROID STIMULATING HORMONE INCREASED 19
812 BRADYPHRENIA 19
813 BRONCHOSPASM 19
814 CARDIOMEGALY 19
815 CENTRAL NERVOUS SYSTEM LESION 19
816 CONGENITAL HYDRONEPHROSIS 19
817 CRYPTORCHISM 19
818 DRUG DEPENDENCE 19
819 DRY THROAT 19
820 EUPHORIC MOOD 19
821 GENERALISED TONIC-CLONIC SEIZURE 19
822 HEPATIC CYTOLYSIS 19
823 INCREASED TENDENCY TO BRUISE 19
824 LOCALISED INFECTION 19
825 MALABSORPTION 19
826 MENTAL STATUS CHANGES 19
827 NEUTROPHIL COUNT DECREASED 19
828 PRODUCT PACKAGING QUANTITY ISSUE 19
829 RED BLOOD CELL COUNT DECREASED 19
830 RENAL FAILURE ACUTE 19
831 RHINITIS 19
832 SARS-COV-2 TEST POSITIVE 19
833 SENSATION OF FOREIGN BODY 19
834 SKIN ODOUR ABNORMAL 19
835 SNORING 19
836 SUSPECTED OFF LABEL USE 19
837 TONGUE DISORDER 19
838 ABORTION THREATENED 18
839 ABSCESS 18
840 BIPOLAR DISORDER 18
841 BLOOD CALCIUM INCREASED 18
842 BLOOD OESTROGEN INCREASED 18
843 BLOOD PRESSURE DIASTOLIC DECREASED 18
844 DERMATITIS ALLERGIC 18
845 DIVERTICULUM 18
846 DIZZINESS POSTURAL 18
847 DRUG DISPENSING ERROR 18
848 EYELIDS PRURITUS 18
849 FAECES DISCOLOURED 18
850 FOREIGN BODY SENSATION IN EYES 18
851 GENITAL HAEMORRHAGE 18
852 GROIN PAIN 18
853 HEPATITIS 18
854 HIDRADENITIS 18
855 HYPERAESTHESIA 18
856 INCONTINENCE 18
857 INFUSION SITE PRURITUS 18
858 LYMPHOPENIA 18
859 MALIGNANT NEOPLASM PROGRESSION 18
860 MATERNAL EXPOSURE DURING BREAST FEEDING 18
861 NEOPLASM MALIGNANT 18
862 PETECHIAE 18
863 PHOTOPSIA 18
864 PLAGIOCEPHALY 18
865 PNEUMONITIS 18
866 POLYP 18
867 PRODUCT DISTRIBUTION ISSUE 18
868 PRODUCT PACKAGING ISSUE 18
869 PSYCHOMOTOR HYPERACTIVITY 18
870 RESPIRATORY DISTRESS 18
871 SALIVARY HYPERSECRETION 18
872 SKIN WARM 18
873 SPINAL FRACTURE 18
874 STILLBIRTH 18
875 THERAPY PARTIAL RESPONDER 18
876 TRANSAMINASES INCREASED 18
877 VITAMIN D DECREASED 18
878 ACCIDENTAL OVERDOSE 17
879 ADRENAL DISORDER 17
880 AFFECTIVE DISORDER 17
881 APPLICATION SITE EXFOLIATION 17
882 ASTHENOPIA 17
883 BLOOD PRESSURE DIASTOLIC ABNORMAL 17
884 BODY HEIGHT DECREASED 17
885 CHOLECYSTITIS 17
886 CONGENITAL UMBILICAL HERNIA 17
887 DRUG ABUSE 17
888 DYSPAREUNIA 17
889 ENCEPHALOPATHY 17
890 EYELID OEDEMA 17
891 GASTROINTESTINAL INFECTION 17
892 GLOSSODYNIA 17
893 HAIR COLOUR CHANGES 17
894 HELLP SYNDROME 17
895 HYPERACUSIS 17
896 HYPOKINESIA 17
897 HYPOTONIA 17
898 INFUSION SITE EXTRAVASATION 17
899 INTENTIONAL DRUG MISUSE 17
900 JOINT DISLOCATION 17
901 KERATOCONUS 17
902 LARGE INTESTINE POLYP 17
903 MALIGNANT MELANOMA 17
904 METASTASES TO LYMPH NODES 17
905 NASAL DRYNESS 17
906 OESOPHAGITIS 17
907 PLACENTA ACCRETA 17
908 PLANTAR FASCIITIS 17
909 PREMATURE AGEING 17
910 PULMONARY FIBROSIS 17
911 SINUS TACHYCARDIA 17
912 SUBCLAVIAN VEIN THROMBOSIS 17
913 TERMINAL INSOMNIA 17
914 THERAPEUTIC REACTION TIME DECREASED 17
915 ANGINA PECTORIS 16
916 APPLICATION SITE VESICLES 16
917 ASPIRATION 16
918 BLOOD ALKALINE PHOSPHATASE INCREASED 16
919 CARDIAC ARREST 16
920 CHOLESTASIS 16
921 CIRCULATORY COLLAPSE 16
922 COMPLETED SUICIDE 16
923 DENTAL CARIES 16
924 DEPRESSION SUICIDAL 16
925 DEPRESSIVE SYMPTOM 16
926 DEVICE DELIVERY SYSTEM ISSUE 16
927 ELECTRIC SHOCK SENSATION 16
928 FACE OEDEMA 16
929 FOETAL HEART RATE ABNORMAL 16
930 FRUSTRATION TOLERANCE DECREASED 16
931 GLAUCOMA 16
932 HEPATIC FAILURE 16
933 HERPES SIMPLEX 16
934 HYPERPROLACTINAEMIA 16
935 HYPOPLASTIC LEFT HEART SYNDROME 16
936 INFERTILITY 16
937 INJECTION SITE DISCOMFORT 16
938 INJECTION SITE NODULE 16
939 JOINT NOISE 16
940 LYME DISEASE 16
941 MASS 16
942 MELANOCYTIC NAEVUS 16
943 MUCOUS STOOLS 16
944 MUSCLE ATROPHY 16
945 NEONATAL RESPIRATORY DISTRESS 16
946 NIPPLE PAIN 16
947 PARANASAL SINUS DISCOMFORT 16
948 PERICARDIAL EFFUSION 16
949 PERSONALITY CHANGE 16
950 PLATELET COUNT INCREASED 16
951 POLYMENORRHOEA 16
952 PREMATURE SEPARATION OF PLACENTA 16
953 PRODUCT COLOUR ISSUE 16
954 PRODUCT SIZE ISSUE 16
955 PULMONARY ARTERY STENOSIS CONGENITAL 16
956 ROSACEA 16
957 SCOLIOSIS 16
958 SEROTONIN SYNDROME 16
959 SLUGGISHNESS 16
960 SPINAL PAIN 16
961 SWELLING OF EYELID 16
962 SYNOVIAL CYST 16
963 TOOTH ABSCESS 16
964 ULCER 16
965 UTERINE CANCER 16
966 VISUAL FIELD DEFECT 16
967 VULVOVAGINAL MYCOTIC INFECTION 16
968 VULVOVAGINAL PAIN 16
969 WOUND INFECTION 16
970 ABORTION MISSED 15
971 ADNEXA UTERI PAIN 15
972 AKATHISIA 15
973 AMNIOTIC CAVITY INFECTION 15
974 APPLICATION SITE DRYNESS 15
975 BLEPHARITIS 15
976 BREAST CYST 15
977 BREECH PRESENTATION 15
978 CARDIAC MURMUR 15
979 CEREBRAL DISORDER 15
980 CEREBRAL HAEMORRHAGE 15
981 COMPLICATION ASSOCIATED WITH DEVICE 15
982 DRUG EXPOSURE BEFORE PREGNANCY 15
983 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15
984 ERYTHEMA NODOSUM 15
985 ERYTHEMA OF EYELID 15
986 EYE INFLAMMATION 15
987 FACIAL PARALYSIS 15
988 FEELING OF DESPAIR 15
989 GASTROINTESTINAL HAEMORRHAGE 15
990 GESTATIONAL HYPERTENSION 15
991 GINGIVAL PAIN 15
992 GLYCOSYLATED HAEMOGLOBIN INCREASED 15
993 HANGOVER 15
994 HIP FRACTURE 15
995 IMMUNE SYSTEM DISORDER 15
996 INFUSION SITE BRUISING 15
997 INVASIVE DUCTAL BREAST CARCINOMA 15
998 LOSS OF LIBIDO 15
999 MAST CELL ACTIVATION SYNDROME 15